When restricted to the group of BECLIN 1-positive tumours, it was found that 20 out of 21 patients bearing a tumour also positive for LC3 were still alive, while 6 out of 9 of those patients bearing a tumour negative for LC3 were DOD, at 5 years after diagnosis (Table 4(a)). The gene discussed is BECN1; the disease is neoplasm.